Publications
-
Mato S, Carità L, Colmenero A, Andrés M, Balagué O, Andión M, Astigarraga I, Celis-Passini V, Mendoza C, Guerra-García P, Valero L, Galera A, Tallón M, Pol M, Castrejón-de-Anta N, Frauenfeld L, Garcia N, Campo E, Salaverria I and Verdú-Amorós J.
Comprehensive analysis of relapsed-refractory mature B-cell non-Hodgkin lymphoma in children and adolescents
BRITISH JOURNAL OF HAEMATOLOGY . : .
-
Mato S, Castrejón-de-Anta N, Colmenero A, Carità L, Salmerón-Villalobos J, Ramis-Zaldivar JE, Nadeu F, Garcia N, Wang L, Verdú-Amorós J, Andrés M, Conde N, Celis-Passini V, Ortega MJ, Galera A, Astigarraga I, Perez-Alonso V, Quiroga E, Jiang A, Scott DW, Campo E, Balagué O and Salaverria I.
MYC-rearranged mature B-cell lymphomas in children and young adults are molecularly Burkitt Lymphoma
BLOOD CANCER JOURNAL . 14(1): 171-171. Number of citations: 1
-
Sánchez-Espino LF, Ivars M, Prat-Torres CS, Lavarino C, Gene-Olaciregui N, Rovira-Zurriaga C, Celis-Passini V, Miguel Bejarano Serrano and Baselga E.
Single dominant lesion in capillary malformation-arteriovenous malformation (CM-AVM) RASA1 syndrome
PEDIATRIC DERMATOLOGY . 41(5): 861-865.
-
Salmerón-Villalobos J, Castrejon-de-Anta N, Guerra-Garcia P, Ramis-Zaldivar JE, López-Guerra M, Mato S, Colomer D, Diaz Crespo FJ, Menarguez J, Garrido-Pontnou M, Andres M, Garcia-Fernandez E, Llavador M, Frigola G, Garcia N, Gonzalez-Farre B, Martin-Guerrero I, Garrido-Colino C, Astigarraga I, Fernandez A, Verdu-Amorós J, Gonzalez Muñiz S, González-Martínez B, Celis-Passini V, Campo E, Balagué O and Salaverria I.
Decoding the molecular heterogeneity of pediatric monomorphic post-solid organ transplant lymphoproliferative disorders
Blood . 142(5): 434-445. Number of citations: 8
-
Salmerón-Villalobos J, Ramis-Zaldivar JE, Balagué O, Verdú-Amorós J, Celis-Passini V, Sábado C, Garrido M, Mato S, Uriz J, Ortega MJ, Gutierrez-Camino A, Sinnett D, Illarregi U, Carron M, Regueiro A, Galera A, Gonzalez-Farré B, Campo E, Garcia N, Colomer D, Astigarraga I, Andrés M, Llavador M, Martin-Guerrero I and Salaverria I.
Diverse mutations and structural variations contribute to Notch signaling deregulation in paediatric T-cell lymphoblastic lymphoma
PEDIATRIC BLOOD & CANCER . 69(11): . Number of citations: 7
-
Kobialka P, Sabata H, Vilalta O, Gouveia L, Angulo-Urarte A, Muixí L, Zanoncello J, Muñoz-Aznar O, Gene-Olaciregui N, Fanlo L, Esteve-Codina A, Lavarino C, Javierre BM, Celis-Passini V, Rovira-Zurriaga C, López-Fernández S, Baselga E, Mora J, CastilloSD and Graupera M.
The onset of PI3K-related vascular malformations occurs during angiogenesis and is prevented by the AKT inhibitor miransertib
EMBO Molecular Medicine . 14(7): . Number of citations: 33
-
Viñas-Giménez L, Rincón R, Colobran R, de la Cruz X, Celis-Passini V, Dapena JL, Alsina L, Sayós J and Martínez-Gallo M.
Case Report: Characterizing the Role of the STXBP2-R190C Monoallelic Mutation Found in a Patient With Hemophagocytic Syndrome and Langerhans Cell Histiocytosis
FRONTIERS IN IMMUNOLOGY . 12: 723836-723836. Number of citations: 3
-
Carrere X, Pinto N, Gene-Olaciregui N, Galluzzo L, Rossetti E, Celis-Passini V, Salvador-Marcos N, Chantada G, Braier J, Lavarino C and Felizzia G.
High prevalence of BRAF(V600E) in patients with cholestasis, sclerosing cholangitis or liver fibrosis secondary to Langerhans cell histiocytosis
PEDIATRIC BLOOD & CANCER . 68(7): 29115. Number of citations: 4
-
Castillo H, Pascual-Pastó G, Pérez-Jaume S, Resa-Parés C, Vilà-Ubach M, Monterrubio C, Jimenez-Cabaco A, Baulenas-Farrés M, Muñoz-Aznar O, Salvador-Marcos N, Cuadrado-Vilanova M, Gene-Olaciregui N, Balaguer-Lluna L, Burgeño-Sandoval V, Vicario FJ, Manzanares-Quintela A, Castañeda-Heredia A, Santa-María López V, Cruz-Martínez O, Celis-Passini V, Morales-La Madrid A, Garraus-Oneca M, Gorostegui M, Vancells M, Carrasco-Torrents R, Krauel L, Torner-Rubies F, Suñol M, Lavarino C, Mora J and Carcaboso AM.
Prognostic value of patient-derived xenograft engraftment in pediatric sarcomas
JOURNAL OF PATHOLOGY CLINICAL RESEARCH . 7(4): 338-349. Number of citations: 19
-
Rössler J, Baselga E, Davila V, Celis-Passini V, Diociaiuti A, El Hachem M, Mestre S, Haeberli D, Prokop A, Hanke C, Loichinger W, Quéré I, Baumgartner I, Niemeyer CM and Kapp FG.
Severe adverse events during sirolimus "off-label" therapy for vascular anomalies
PEDIATRIC BLOOD & CANCER . 68(8): . Number of citations: 27